Andersons pediatric cardiology 1676
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.51 KB, 3 trang )
timeofseptalmyectomy.AnnThoracSurg.
2014;97(1):118–123.
209.BrentLB,AburanoA,FisherDL,etal.Familial
muscularsubaorticstenosis:anunrecognized
formof“idiopathicheartdiseases,”withclinical
andautopsyobservations.Circulation.
1960;21:167–180.
210.MaronBJ,WolfsonJK,EpsteinSE,Roberts
WC.Intramural(“smallvessel”)coronaryartery
diseaseinhypertrophiccardiomyopathy.JAm
CollCardiol.1986;8(3):545–557.
211.MaronBJ,RobertsWC.Quantitativeanalysisof
cardiacmusclecelldisorganizationinthe
ventricularseptumofpatientswithhypertrophic
cardiomyopathy.Circulation.1979;59(4):689–
706.
212.HarrisonDC,BraunwaldE,GlickG,etal.
Effectsofbetaadrenergicblockadeonthe
circulationwithparticularreferenceto
observationsinpatientswithhypertrophic
subaorticstenosis.Circulation.1964;29(1):84–
98.
213.BraunwaldE,EbertPA.Hemogynamic
alterationsinidiopathichypertrophicsubaortic
stenosisinducedbysympathomimeticdrugs.Am
JCardiol.1962;10:489–495.
214.MenonSC,AckermanMJ,CettaF,O'LearyPW,
EidemBW.Significanceofleftatrialvolumein
patients<20yearsofagewithhypertrophic
cardiomyopathy.AmJCardiol.
2008;102(10):1390–1393.
215.TaggartNW,CettaF,O'LearyPW,SewardJB,
EidemBW.Leftatrialvolumeinchildren
withoutheartdiseaseandinthosewith
ventricularseptaldefectorpatentductus
arteriosusorhypertrophiccardiomyopathy.AmJ
Cardiol.2010;106(10):1500–1504.
216.HussainT,DragulescuA,BensonL,etal.
Quantificationandsignificanceofdiffuse
myocardialfibrosisanddiastolicdysfunctionin
childhoodhypertrophiccardiomyopathy.Pediatr
Cardiol.2015;36(5):970–978.
217.MohammedA,MertensL,FriedbergMK.
Relationsbetweensystolicanddiastolicfunction
inchildrenwithdilatedandhypertrophic
cardiomyopathyasassessedbytissuedoppler
imaging.JAmSocEchocardiogr.
2009;22(2):145–151.
218.NihoyannopoulosP,KaratasakisG,Frenneaux
M,McKennaWJ,OakleyCM.Diastolic
functioninhypertrophiccardiomyopathy:
relationtoexercisecapacity.JAmCollCardiol.
1992;19(3):536–540.
219.McMahonCJ,NaguehSF,PignatelliRH,etal.
Characterizationofleftventriculardiastolic
functionbytissuedopplerimagingandclinical
statusinchildrenwithhypertrophic
cardiomyopathy.Circulation.
2004;109(14):1756–1762.
220.MaronBJ,HaasTS,MaronMS,etal.Leftatrial
remodelinginhypertrophiccardiomyopathyand
susceptibilitymarkersforatrialfibrillation
identifiedbycardiovascularmagneticresonance.
AmJCardiol.2014;113(8):1394–1400.
221.GuttmannOP,PavlouM,O'MahonyC,etal.
Predictionofthrombo-embolicriskinpatients
withhypertrophiccardiomyopathy(HCMRiskCVA).EurJHeartFail.2015;17(8):837–845.
222.NistriS,OlivottoI,BetocchiS,etal.Prognostic
significanceofleftatrialsizeinpatientswith
hypertrophiccardiomyopathy(fromtheItalian
registryforhypertrophiccardiomyopathy).AmJ
Cardiol.2006;98(7):960–965.
223.O'MahonyC,JichiF,PavlouM,etal.Anovel
clinicalriskpredictionmodelforsuddencardiac
deathinhypertrophiccardiomyopathy(HCM
risk-SCD).EurHeartJ.2014;35(30):2010–
2020.
224.MaronMS,RowinEJ,OlivottoI,etal.
Contemporarynaturalhistoryandmanagement
ofnonobstructivehypertrophiccardiomyopathy.
